The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside.

The main theme of the 2012 symposium will be Efficacy of biomarkers and personalized cancer therapeutics. This theme will be elaborated in various plenary sessions:
• Fundamental concepts and strategies to improve efficacy of therapeutics
• WIN Consortium – Global innovative clinical trials
• Biology-driven diagnostics and therapeutics
• Combinatorial biomarkers and efficacy of therapeutics
• Innovative targets and new drug discoveries
• Innovative therapeutics and clinical trials
• Systems biology and bioinformatics

Location